Pharmacologic management of posttraumatic stress disorder

Perspectives in Psychiatric Care

Volumn 43, Issue 1, 2007, Pages 55-59

  Antai Otong, Deborah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

ACUTE DISEASE; CHRONIC DISEASE; DISASTER; FORECASTING; HUMAN; NURSING; ORGANIZATION AND MANAGEMENT; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PREVALENCE; PROFESSIONAL PRACTICE; PSYCHIATRIC NURSING; PSYCHOTHERAPY; REVIEW; RISK FACTOR;

ACUTE DISEASE; ADRENERGIC ANTAGONISTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DISASTERS; FORECASTING; HUMANS; PRESCRIPTIONS, DRUG; PREVALENCE; PROFESSIONAL AUTONOMY; PSYCHIATRIC NURSING; PSYCHOTHERAPY; RISK FACTORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 33846503459     PISSN: 00315990     EISSN: 17446163     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2007.00096.x     Document Type: Review

References (28)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, 4th ed. (revised). Washington, DC: Author.
2. Asnis, G. M., Kohn, S. R., Henderson, M., & Brown, N. L. (2004). SSRIs versus non-SSRIs in post-traumatic stress disorder: An update with recommendations. Drugs, 64, 383-404.
3. Berlant, J. L. (2004). Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. BioMed Central Psychiatry, 4:24; doi: 10.1186/1471-244X-4-24. Electronic version http://www.biomedcentral.com/1471- 244X/4/24 (Accessed October 30, 2006).
4. Berlant, J., & van Kammen, D. P. (2002). Open-label topiramate as primary of adjunctive therapy in chronic civilian posttraumatic stress disorder: A preliminary report. Journal of Clinical Psychiatry, 63, 15-20.
5. Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, E. D., Charney, D. S., et al. (1995). The development of a clinician-administered PTSD scale. Journal of Traumatic Stress, 8, 75-90.
6. Bleich, A., Koslowsky, M., Dolev, A., & Lerer, B. (1997). Posttraumatic stress disorder and depression: An analysis of comorbidity. British Journal of Psychiatry, 170, 479-482.
7. Blier, P. (2001). Pharmacology of rapid-onset antidepressant treatment strategies. Journal of Clinical Psychiatry, 62, Suppl 15, 12-17.
8. Brady, K. T., & Clary, C. M. (2003). Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline. Comprehensive Psychiatry, 44, 360-369.
9. Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., et al. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. Journal of the American Medical Association, 283, 1837-1844.
10. Campbell-Sills, L., Cohan, S. L., & Stein, M. B. (2006). Relationship of resilience to personality, coping and psychiatric symptoms in young adults. Behaviour Research and Therapy, 44, 585-599.
11. Davidson, J. R., Payne, V. M., Connor, K. M., Foa, E. B., Rothbaum, B. O., Hertzberg, M. A., et al. (2005). Trauma, resilience, and saliostasis: Effects of treatment in posttraumatic stress disorder. International Clinical Psychopharmacology, 20, 43-48.
12. Davidson, J. R., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farjel, G. M. (2001). Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Archives of General Psychiatry, 58, 485-492.
13. Gurvits, T. V., Metzger, L. J., Lasko, N. B., Cannistraro, P. A., Tarhan, A. S., et al. (2006). Subtle neurologic compromise as a vulnerability factor for combat-related posttraumatic stress disorder: Results of a twin study. Archives of General Psychiatry, 63, 571-576.
14. Hamner, M. B., Deitsch, S. E., Brodrick, P. S., et al. (2003). Quetiapine treatment in patients with posttraumatic stress disorder: An open adjunctive therapy. Journal of Clinical Psychiatry, 23, 15-20.
15. Iancu, I., Rosen, Y., & Moshe, K. (2002). Antiepileptic drugs in posttraumatic stress disorder. Clinical Neuropharmacology, 25, 225-229.
16. Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., Nelson, C. B. (1995). Posttraumatic disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52, 1048-1060.
17. Maher, M. J., Rego, S. A., & Asnis, G. M. (2006). Sleep disturbances in patients with post-traumatic stress disorder: Epidemiology, impact and approaches to management. CNS Drugs, 20, 567-590.
18. National Center for Posttraumatic Stress Disorder. Retrieved June 3, 2006, from http://www.ncptsd.va.gov/facts/general/fs_epidemiological.html
19. Oquendo, M., Brent, D. A., Birmaher, B., Greenhill, L., Kolko, D., et al. (2005). Posttraumatic stress disorder comorbid with major depression: Factors mediating the association with suicidal behavior. American Journal of Psychiatry, 162, 560-566.
20. Petty, F., Brannan, S., Casada, J., et al. (2001). Olanzapine treatment for posttraumatic stress disorder: An open-label study. International Clinical Psychopharmacology, 16, 331-337.
21. Pitman, R. K., & Delahanty, D. L. (2005). Conceptually driven pharmacologic approaches to acute trauma. CNS Spectrum, 10, 99-106.
22. Pitman, R. K., Sanders, K. M., Zusman, R. M., Healey, A. R., Cheema, F., Lasko, N. B., et al. (2002). Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biological Psychiatry, 51, 189-192.
23. Rimmö, Ö., Åberg, P.-A., & Fredrikson, M. (2005). Trauma exposure and post-traumatic stress disorder in the general population. Acta Psychiatrica Scandinavica, 111, 291-299.
24. Semple, W. E., Goyer, P. F., McCormick, R., Donovan, B., Muzic, R. F. Jr et al. (2000). Higher brain blood flow at amygdala and lower frontal cortex blood flow in PTSD patients with comorbid cocaine and alcohol abuse compared with normals. Psychiatry, 63, 65-74.
25. Shin, L. M., Orr, S. P., Carson, M. A., Rauch, S., Macklin, M. L., Lasko, N. B., et al. (2004). Regional blood flow in the amygdale and medical prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Archives of General Psychiatry, 61, 168-176.
26. Stein, M. B. (2005). Anxiety disorders: Somatic treatment. In B. J. Sadock & V. A. Sadock (Eds.) Kaplan & Sadock's Comprehensive Textbook of General Psychiatry, 8th ed. (pp. 1780-1788). Philadelphia: Lippincott Williams & Wilkins.
27. Vaiva, G., Ducrocq, F., Jezequel, K., Averland, B., Lestavel, P., Brunet, A., et al. (2003). Immediate treatment with propranolol decreases posttraumatic stress disorder two months after Trauma. Biological Psychiatry, 54, 947-949.
28. Zatzick, D. F., Marmar, C. R., & Weiss, D. S. (1997). PTSD and functioning and quality of life outcomes in a nationally representative sample of male Vietnam veterans. American Journal of Psychiatry, 154, 1690-1695.